Due to their potential effect on prognosis and clinical management, four biomarkers are tested consistently in biopsies and excision specimens of BC: estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and Ki67 antigen [11]. Here, ERBB2 is linked to breast cancer.